PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy

Approximately 500,000 new cases of head and neck squamous cell carcinoma (HNSCC) are reported annually. Radiation therapy is an important treatment for oral squamous cell carcinoma (OSCC). The survival rate of patients with HNSCC remained low (50%) in decades because of radiation therapy failure cau...

Full description

Saved in:
Bibliographic Details
Published in:PLoS One
Main Authors: Chuang, Fu-Cheng, Wang, Chih-Chun, Chen, Jian-Han, Hwang, Tzer-Zen, Yeh, Shyh-An, Su, Yu-Chieh
Format: Artigo
Language:Inglês
Published: Public Library of Science 2021
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7817006/
https://ncbi.nlm.nih.gov/pubmed/33471836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0245715
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items